argenx SE
has potential to transform | argenx SE
Company
Deck Type
Sector
Industry
Deck date
January 2024
Slide
18 of 27
Related slides by other companies
Dare Bioscience
Investor Presentation
February 2023
dar working to accelerate innovation in women health upcoming program milestones dare | Dare Bioscience
Larimar Therapeutics
Investor Presentation
November 2023
top line phase cohort data initiation in | Larimar Therapeutics
ATAI
Investor Presentation
October 2022
achieved and expected catalysts phase results phase a results phase results phase results phase results phase results phase results phase results phase initiation phase a results phase study initiation study results phase a initiation phase initiation phase a results phase initiation study initiation in cash as of june plus access to up to from term loan facility provides runway into we will build on recent success by delivering several meaningful anticipated across our key programs through with | ATAI
MindMed
Investor Presentation
November 2024
for gad phase study designs voyage panorama | MindMed
Other recent decks by argenx SE
See all presentations (28 decks)
Results
February 2024
Investor Presentation
December 2023
Investor Presentation
November 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights